Antibodies to glutamic acid decarboxylase in young Chinese diabetic patients

Annals of Clinical Biochemistry

Volumn 35, Issue 6, 1998, Pages 761-767

  Ko, Gary T C ^a   Chan, Juliana C N ^a   Yeung, Vincent T F ^a   Chow, Chun Chung ^a   Li, June K Y ^a   Lau, Maggie S W ^a   Mackay, Ian R ^b   Rowley, Merrill J ^b   Zimmet, Paul ^c   Cockram, Clive S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MONASH UNIVERSITY   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

C peptide; Glucagon stimulation test; Insulin

Indexed keywords

ANTIBODY; C PEPTIDE; GLUCAGON; GLUTAMATE DECARBOXYLASE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; AUTOIMMUNITY; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHILD; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; DISEASE MARKER; HUMAN; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 7844250480     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329803500609     Document Type: Article

References (29)

1. Ziegler AG, Herskowitz RD, Jackson RA, Soeldner JS, Eisenbarth GS. Predicting type 1 diabetes. Diabetes Care 1990; 13: 762-5
2. Castano L, Eisenbarth G. Type 1 diabetes: a chronic autoimmune disease of human, mouse and rat. Ann Rev Immunol 1990; 8: 647-9
3. Dean BM, Bottazzo GF, Cudworth AG. IgG subclass distribution in organ-specific autoantibodies: the relationship to complement-fixing ability. Clin Exp Immunol 1983; 52: 61-6
4. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, et al. Insulin antibodies in insulin-dependent diabetes before insulin treatment. Science 1988; 222: 1337-9
5. Baekkeskov S, Aanstoot H-J, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-6
6. Rowley MJ, Mackay IR, Chen QY, Knowles WJ, Zimmet PZ. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 1992; 41: 548-51
7. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD 65) shows that 65K autoantibody positively at onset predicts diabetes type. J Clin Invest 1993; 91: 368-74
8. Tuomilehto J, Zimmet P, Mackay IR, Koskela R, Vidgren G, Toivanen L, et al. Antibodies to glutamic acid decarboxylase as predictors of IDDM before clinical onset of disease. Lancet 1994; 343: 1383-5
9. Verge CF, Howard NJ, Rowley MJ, Mackay IR, Zimmet PZ, Egan M, et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 1994; 37: 1113-20
10. Diabetes Epidemiology Research International Group. Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes 1988; 37: 1113-9
11. Wong GWK, Leung SSF, Opphenheimer SJ. Epidemiology of IDDM in southern Chinese children in Hong Kong. Diabetes Care 1993; 16: 926-8
12. Chan JCN, Yeung VTK, Chow CC, Ko GTC, Mackay IR, Rowley MJ, et al. Pancreatic β cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus. Diab Res Clin Pract 1996; 32: 27-34
13. Zimmet PZ, Rowley MJ, Mackay IR, Knowles WJ, Chen QY, Chapman LH, et al. The ethnic distribution of antibodies to glutamic acid decarboxylase: presence and levels in insulin-dependent mellitus in Europid and Asian subjects. J Diabet Complications 1993; 7: 1-7
14. Friedewald WT, Levy RI, Fredrickason DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
15. Madsbad S, Krarup T, McNair P, Christiansen C, Fabert OK, Transbol OK, et al. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 1981; 210: 153-6
16. Laakso M, Pyorala RE. Age of onset and type of diabetes. Diabetes Care 1985; 8: 114-7
17. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-57
18. Chen QY, Rowley MJ, Bryne GC, Jones TW, Tuomi T, Knowles WJ, et al. Antibodies to glutamic acid decarboxylase in Australian children wih insulin-dependent diabetes mellitus and their first degree relatives. Pediatr Res 1993; 34: 785-90
19. Tuomi T, Zimmet P, Rowley MJ, Min HK, Vichayanrat A, Lee HK, et al. Differing frequency of autoantibodies to glutamic acid decarboxylase among Koreans. Thais and Australians with diabetes mellitus. Clin Immunol Immunopathol 1994; 74: 202-6
20. Roll U, Christie MR, Standl E, Ziegler AG. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type 1 diabetic patients. Diabetes 1994; 43: 154-60
21. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42: 359-62
22. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies of glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 1994; 11: 299-303
23. Takino H, Kawasaki E, Yano M, Matsumoto K, Uotani S, Okuno S. The heterogeneity of whole-islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase. J Autoimmun 1994; 6: 389-98
24. Zanone MM, Petersen JS, Peakman M, Mathias CJ, Watkins PJ, Dyrberg T, et al. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy. Diabetes 1994; 43: 1146-51
25. Zhou ZG, Wang JM, Wen JX, Wu HW. Effects of human glutamic acid decarboxylase autoantibody (GAD-Ab) on human fetal islet beta cells in vitro. Abstracts of Third International Diabetes Federation Western Pacific Regional Congress. 25-28 September 1996, Hong Kong, p. 58
26. Aitman TJ, Todd JA. Molecular genetics of diabetes mellitus. Baillière's Clin Endocrinol Metab 1995; 9: 631-56
27. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356: 162-4
28. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173
29. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 1994; 43: 741-5